News articles about Allscripts Healthcare Solutions (NASDAQ:MDRX) have been trending positive on Friday, according to Accern Sentiment. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a news sentiment score of 0.26 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 46.1939248791946 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the media headlines that may have impacted Accern Sentiment’s rankings:

MDRX has been the subject of a number of recent analyst reports. Cantor Fitzgerald raised Allscripts Healthcare Solutions from a “neutral” rating to an “overweight” rating and set a $12.00 price objective for the company in a research note on Tuesday, August 15th. Robert W. Baird upped their price objective on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, November 3rd. KeyCorp reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a research note on Friday, October 27th. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $15.06.

Shares of Allscripts Healthcare Solutions (MDRX) traded down $0.09 during mid-day trading on Friday, reaching $12.58. The company’s stock had a trading volume of 574,777 shares, compared to its average volume of 1,830,000. Allscripts Healthcare Solutions has a fifty-two week low of $9.96 and a fifty-two week high of $14.45. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.93 and a current ratio of 0.98. The stock has a market capitalization of $2,260.00, a P/E ratio of 30.30, a PEG ratio of 2.32 and a beta of 1.34.

In other Allscripts Healthcare Solutions news, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total transaction of $67,600.00. Following the sale, the executive vice president now directly owns 196,607 shares in the company, valued at $2,658,126.64. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $13.56, for a total value of $203,400.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 35,000 shares of company stock worth $473,800. Company insiders own 0.75% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/11/10/allscripts-healthcare-solutions-mdrx-given-daily-news-impact-rating-of-0-26.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.